OBJECTIVE: To investigate attitudes to directly observed antiretroviral therapy (DOT ART) among HIV infected adults attending a workplace HIV care programme in South Africa. METHODS: Clients attending workplace HIV clinics in two regions were interviewed using a semi-structured questionnaire. RESULTS: 100 individuals (99% male, mean age 40.2 years) participated, 61% were already taking ART by self administration. 71% had previous tuberculosis (TB) with the majority having received DOT for TB. 65% of individuals indicated that they would not like to receive ART by DOT-the main reason given was a desire to take responsibility for their own treatment. This contrasted with 79% who thought TB treatment by DOT a good idea. On questioning about disclosure, 70% reported disclosure to their sexual partners and 21% to fellow workers. 78% of individuals indicated willingness to support someone else taking ART. CONCLUSION: ART by DOT was not an immediately popular concept with our patients, primarily because of a desire to retain responsibility for their own treatment. More work is needed to understand what key elements of treatment support are needed to promote adherence.
OBJECTIVE: To investigate attitudes to directly observed antiretroviral therapy (DOT ART) among HIV infected adults attending a workplace HIV care programme in South Africa. METHODS: Clients attending workplace HIV clinics in two regions were interviewed using a semi-structured questionnaire. RESULTS: 100 individuals (99% male, mean age 40.2 years) participated, 61% were already taking ART by self administration. 71% had previous tuberculosis (TB) with the majority having received DOT for TB. 65% of individuals indicated that they would not like to receive ART by DOT-the main reason given was a desire to take responsibility for their own treatment. This contrasted with 79% who thought TB treatment by DOT a good idea. On questioning about disclosure, 70% reported disclosure to their sexual partners and 21% to fellow workers. 78% of individuals indicated willingness to support someone else taking ART. CONCLUSION: ART by DOT was not an immediately popular concept with our patients, primarily because of a desire to retain responsibility for their own treatment. More work is needed to understand what key elements of treatment support are needed to promote adherence.
Authors: P Farmer; F Léandre; J S Mukherjee; M Claude; P Nevil; M C Smith-Fawzi; S P Koenig; A Castro; M C Becerra; J Sachs; A Attaran; J Y Kim Journal: Lancet Date: 2001-08-04 Impact factor: 79.321
Authors: C Kilewo; A Massawe; E Lyamuya; I Semali; F Kalokola; E Urassa; M Giattas; F Temu; K Karlsson; F Mhalu; G Biberfeld Journal: J Acquir Immune Defic Syndr Date: 2001-12-15 Impact factor: 3.731
Authors: Larry R Kirkland; Margaret A Fischl; Karen T Tashima; David Paar; Thomas Gensler; Neil M Graham; Haitao Gao; Jacqueline R Carranza Rosenzweig; Daniel R McClernon; Ginger Pittman; Siegrid M Hessenthaler; Jaime E Hernandez Journal: Clin Infect Dis Date: 2002-01-04 Impact factor: 9.079
Authors: R L Klitzman; S B Kirshenbaum; B Dodge; R H Remien; A A Ehrhardt; M O Johnson; L E Kittel; S Daya; S F Morin; J Kelly; M Lightfoot; M J Rotheram-Borus Journal: AIDS Care Date: 2004-07
Authors: Grace E Macalino; Jennifer A Mitty; Lauri B Bazerman; Kavita Singh; Michelle McKenzie; Timothy Flanigan Journal: Clin Infect Dis Date: 2004-06-01 Impact factor: 9.079